Home > Boards > US Listed > Telecommunications Hardware >

Kallo, Inc. (KALO)

KALO RSS Feed
Add KALO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator shl468
Search This Board:
Last Post: 7/23/2014 11:42:59 AM - Followers: 76 - Board type: Free - Posts Today: 0

Kallo, Inc. (KALO) leverages a suite of technologies to improve the quality and efficiency of care in the $6.3 trillion global healthcare industry. Offering centralized, congruent solutions that attend healthcare and business issues, the company addresses the needs of hospitals, ministries of health, physicians, and other healthcare organizations.

As a result of an expanding and aging population, coupled with an increasing number of people suffering from chronic diseases and lifestyle related conditions, healthcare expenditures continue to grow. Kallo is focused on introducing new healthcare technology that helps contain costs, enable better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.

The tailored solutions offered by Kallo complement existing infrastructure, workflows, and processes, increasing both uptime and productivity. The company’s suite of products complies with international, national, and regional standards, and its stringent quality control ensures repeatable, process-driven delivery for maximum performance.

Kallo’s executives and directors bring rich and diverse industry knowledge. Collectively, the management team reflects the strength of the company’s global network and the diversity of its global culture. The team’s entrepreneurship, passion, experience, and knowledge of healthcare enable Kallo to continually deliver higher standards.

 


Investment Highlights

  • Diverse Product Portfolio Allows Entrance Into Key Markets
    Guided by Proficient, Experienced Management Team
    Intuitive Technology Designed to Enhance Life
    Innovatively Addressing Global Medical Concerns
    Mobile Medical Solutions Applicable Worldwide

 


Solutions

Powerful Portfolio of Technologies Address Global Healthcare Concerns

Kallo’s tailored solutions provide efficient delivery of healthcare services. The company’s technologies complement existing infrastructure, workflows and processes increasing uptime and productivity. All of Kallo’s clinical solutions are in compliance with international, national, and regional standards. The company’s stringent quality control ensures repeatable, process-driven delivery for maximum performance.

!ntegraat

!ntegraat enables any medical device to connect to any EMR, PACS, HIS, RIS, PIS or DI-r, providing a seamless flow of information and data that ensures clinicians have all the needed information to provide patients timely and effective healthcare.

 

Kallo MobileCare™

Kallo MobileCare™ is a comprehensive solution for remote and unreached communities. These mobile clinics are fully equipped with best-in-class medical devices and congruent information systems enabling the centralized coordination of resources and communications through Administration Centres.

The Clinical Command Centres provide support from medical specialists for complex cases through HL7, DICOM, HIPAA (among others) compliant information & telemedicine systems.

Kallo MobileCare™ is deployed with a full training program for ultimate adoption success incorporating medical and technical best practices from across the globe.

 

Kallo Rural-Care MRHDS (Modular Rural Healthcare Delivery Systems)

Kallo Rural-Care MRHDS are pre-fabricated, pre-tested, modular and project determined medical clinics. They are installed with the latest medical equipment from X-Ray and ultrasound to surgery, lab and pharmacy equipment. Based on project requirement, these clinics range from 1200 to 3800 square feet, and can be implemented in rural or disaster-struck areas in a week.

These medical clinics are prefabricated to include a patient exam room, operating room, imaging room, laboratory and dispensary. The staff quarters features a kitchenette, laundry and shower.

 

CygnaMed™

Globalization, inexpensive travel, high treatment costs, long wait times and lack of access to medical facilities have fuelled Medical Tourism to an approx. $25 billion industry. Producing stronger revenues than traditional tourism, Medical Tourism is attractive for many countries seeking to expand economic benefits.

 

oHealth

oHealth provides the infrastructure, technology, training and support to seamlessly integrate with any clinic, laboratory, specialty, hospital, repository or regional and national Health Information Access Layer (HIAL).

 

Keristää™

Keristää is software developed for the collection, integration and communication of clinical information in emergency conditions. The software enables close and instantaneous monitoring of infectious disease outbreaks. Keristää detects and identifies threats at various ports of entry and alerts the Centre for Disease Control/Ministry of Health. Utilizing this data, the software provides physicians the ability to ensure that treatment is based on latest CDC & WHO protocols.

 


Market Opportunity

Global Expenditures for Healthcare Above $6.3 Trillion, U.S. Leads Spending

The global healthcare system is increasingly overburdened with rising numbers of people suffering from chronic diseases and lifestyle related conditions. Due to an expanding and aging global population, healthcare expenditures continue to grow.

The U.S. devotes far more of its economy -- 17.6 percent of GDP in 2010 -- to health than any other country, according to the most recent report from the Organization for Economic Co-operation and Development (OECD).

As budgets tighten and costs rise, developments in healthcare technology help contain costs, contribute to the development of better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.

Kallo’s suite of products - including four copyrighted technologies - is positioned to serve this growing medical technology sector. Through innovation, telecommunication, technology and Total Quality Management, Kallo enables a seamless flow of information/data providing clinicians with all needed information to provide patients timely and effective healthcare.

In providing these technologies, the company has secured the opportunity to participate in several multi-billion dollar market segments.

 


Management Team

The members of Kallo’s management team have rich and diverse industry knowledge, delivering an unprecedented level of commitment and value to the company’s customers and shareholders. These remarkable people reflect the strength of Kallo’s global network and the diversity of its global culture. They have a special responsibility to act with integrity, accept accountability, insist on excellence, support innovation and lead by example.

 

JJohn Cecil - Chairman and CEO, Member of the Board of Directors

With a Bachelor’s degree in electrical engineering, a Master of Science degree in biomedical engineering and a Post Graduate Diploma in medical equipment technology, John Cecil has been in the healthcare industry for 26 years. He is responsible for the invention of the technology and procedure behind depth-of-anesthesia monitoring and non-invasive blood group testing, and was part of the research team that developed the electro-hydraulic shockwave lithotripter, laser lithotripter and transurethral microwave therapy systems. Following a distinguished career, holding such positions as vice president and director with major players in India including GE Medical Systems and Majoris Systems, Cecil immigrated to Canada in 2003 to continue his research and work on several products he is developing. Since then, he has served as director of healthcare with leading software services provider Satyam Computer Service Ltd. and senior healthcare solutions architect with Sun Microsystems. In April 2009, Cecil made the decision to devote his efforts exclusively to the development of a series of breakthrough technologies he has been working on, which are built for use in healthcare management.

 

Vince Leitao - President and COO, Member of the Board of Directors

Having worked in senior sales and marketing roles in the pharmaceutical, medical, and healthcare businesses for 32 years, Vince Leitao is a seasoned business executive. He began his sales career in Goa, India, and has extensive experience strategizing, planning and executing challenging sales and marketing plans. Over his career he has demonstrated an ability to develop and grow new business opportunities and products, and is able to identify, train, motivate and retain the best talent. Since moving to Canada in 1990, Leitao has worked with major companies such as Procter & Gamble and E. Merck, as well as sales director and vice president of sales for Genpharm/Gennium Pharma. He was promoted to director of sales for doubling sales in his territory over the previous year for three straight years. Besides regional players, Leitao has worked and built relations with large medical/pharmaceutical channel partners. He is also the founder of Goapharma, a producer and marketer of specialty dermatology products for very difficult to treat conditions like psoriasis and eczema. He is a hands-on executive who willingly steps in to help close a sale or change a light bulb. A gold medalist public speaker, Leitao is fluent in five languages. His drive, planning and determination are vital contributors to the success of Kallo Inc.

 

Samuel R. Baker - Secretary and Legal Counsel, Member of the Board of Directors

Samuel R. Baker, Q.C., B.A., L.L.B., has been in the legal field for 48 years. He is a senior partner with Baker Law Firm, has provided legal counsel to numerous Fortune 500 and other multinational corporations, and is a founding member and Canadian representative to the Asia-Pacific Lawyers’ Association. He is also the director of the Canada-Netherlands and Canada-Finland Chambers of Commerce, and is the president of the Canada Scandinavian Business Association. His fellowships include: Teaching Fellow (Stanford 1962-63), Alberta Bar (1962), Ontario Bar (1966), and Fellow, Patent and Trademark Institute of Canada (1982). Baker is the author of books and articles on international transactions, joint ventures, technology transfers, establishing a business in Canada, among many other subjects.

 

Lloyd Chiotti – Member of the Board of Directors

Lloyd Chiotti holds an engineering degree and an MBA, both from the University of Toronto. He has worked with Enbridge Gas Distribution (formerly The Consumers Gas Company) for over 30 years. Over the course of his career he has held a number of senior management positions including director of Information Services and a number of regional general manager roles within operations. Most recently he was appointed to the newly formed position of director, distribution asset management, responsible for overseeing the development of Enbridge Gas Distribution’s Strategic Asset Plan. He is actively involved in the natural gas industry. He is currently the dhair of the Asset Management Task Force of the Canadian Gas Association and he is a member of the Distribution Working Committee of the International Gas Union. Throughout his career he has also served on the boards of a number of not-for-profit organizations including: president, Alternative Computer Training for the Disabled; chair, United Way of Peel Campaign 1992; chair of the Board, West Park Healthcare Centre Foundation; vice-chair of the board, Junior Achievement of Toronto; and chair of the board, Toronto Mendelssohn Choir.

 


Kallo, Inc.
15 Allstate Parkway
Suite 600
Markham, ON L32 5B4 Canada
(212) 519-9864
www.KalloInc.ca
Info@KalloInc.ca

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KALO
Current Price
Volume:
Bid Ask Day's Range
Wiki
KALO News: Amended Annual Report (10-k/a) 07/21/2014 05:14:01 PM
KALO News: Current Report Filing (8-k) 07/08/2014 03:21:05 PM
KALO News: Kallo Inc. New Business Developments 06/13/2014 08:15:00 PM
KALO News: Current Report Filing (8-k) 06/13/2014 05:30:33 PM
KALO News: Amended Current Report Filing (8-k/a) 06/13/2014 02:57:04 PM
PostSubject
#3393   its good! now Kallo does not have to shl468 07/23/14 11:42:59 AM
#3392   Did anyone else notice that quality stocks is KC09 07/22/14 07:19:11 PM
#3391   Not sure whey it's the CEO's fault that Isca 07/22/14 10:00:11 AM
#3390   So we can start to move up again. Chris1968 07/22/14 01:51:49 AM
#3389   Some notable updates from today's 10-K/A... kingpindg 07/21/14 06:58:13 PM
#3388   Yea...I saw that, funny how there was no andy e 07/21/14 06:58:12 PM
#3387   Be prepared to wait some more: bh2614 07/21/14 05:52:25 PM
#3386   Are you kidding? The Feds can print bh2614 07/21/14 05:27:42 PM
#3385   News....amended annual report. andy e 07/21/14 05:26:56 PM
#3384   Likely not...what with the economy the way it is. andy e 07/21/14 05:21:05 PM
#3383   I was thinking the portable medical center & bh2614 07/21/14 05:16:45 PM
#3382   Because there are already plenty of medical record andy e 07/21/14 05:10:55 PM
#3381   Product margins and cash flow timing are decision makers. TorontoNewf 07/21/14 01:00:15 PM
#3379   Product profit margins and cash flow issues are TorontoNewf 07/21/14 12:57:53 PM
#3378   There is a great opportunity for KALO on bh2614 07/21/14 09:16:47 AM
#3377   Why does KALO waste money on Quality Stocks? bh2614 07/18/14 01:57:10 PM
#3376   KALO Crosses Borders with Footing in Global Medical QualityStocks 07/18/14 11:13:44 AM
#3375   Some sensitive people don't like my sense of bh2614 07/18/14 08:55:57 AM
#3374   Here is a guy with a since of kingsplay 07/18/14 06:48:34 AM
#3373   As a loyal KALO shareholder, I was pleased bh2614 07/17/14 03:50:49 PM
#3372   They ARE showing you the money - it's bh2614 07/16/14 02:30:54 PM
#3371   Sorry, but didn't invade the sixth floor yet. rube-one 07/15/14 10:59:46 PM
#3370   Thanks for the pics, rube, but,... kingpindg 07/15/14 10:48:22 PM
#3369   thank you shl468 07/15/14 10:35:00 PM
#3368   Thought you guys would like a visual of rube-one 07/15/14 09:26:56 PM
#3367   I would not say Kallo is "covered with TorontoNewf 07/15/14 01:06:41 PM
#3366   I don't see that. If Kallo was covered Isca 07/15/14 12:46:19 PM
#3365   As I understand, Kallo CEO fired previous accountant Sage7243 07/15/14 12:00:41 PM
#3364   Although I am not worried about the cash, TorontoNewf 07/15/14 11:48:10 AM
#3363   Read the 10q debacle carefully. The co has Sage7243 07/12/14 06:06:41 PM
#3362   http://health.yahoo.net/news/s/nm/ebola-deaths-surge-in-sierra-leone-and-liberia blackjackmagraw 07/12/14 02:15:47 PM
#3361   I'm sure they would love nothing more than kingpindg 07/11/14 03:11:46 PM
#3360   No, I'm not selling. My position is bh2614 07/11/14 02:44:02 PM
#3359   So are you selling? Isca 07/11/14 12:57:28 PM
#3358   I wonder if they are comfy in their bh2614 07/11/14 10:29:17 AM
#3357   I wish I had the verve to invest Sage7243 07/11/14 10:26:48 AM
#3356   Something either is happening or is about to Isca 07/09/14 05:54:03 PM
#3355   Going Forward. Move KALO $$$$$ Chris1968 07/09/14 12:30:47 PM
#3354   News today and no volume at all? mikeo56 07/09/14 12:21:35 PM
#3353   18 Jobs are posted now. blackjackmagraw 07/09/14 10:24:19 AM
#3352   Nice office-color me impressed. will it move the pps? DaleG 07/09/14 09:28:46 AM
#3351   KALO Completes Move On Schedule to Markham, Ontario Locale QualityStocks 07/09/14 09:18:24 AM
#3350   NEWS: Kallo Inc. Moves to New Global Head Office zeekhoe 07/09/14 08:51:51 AM
#3349   Dude - You have OCD. I agree. We are Sage7243 07/08/14 11:11:14 PM
#3348   Soon investors will see how undervalued KALO is blackjackmagraw 07/08/14 11:03:47 PM
#3347   Thanks. Looks good... kingpindg 07/08/14 05:52:29 PM
#3346   kalo news... andy e 07/08/14 05:30:54 PM
#3345   I hope the office upgrade means an uptick Sage7243 07/08/14 04:55:56 PM
#3344   sad to see my portfolio of Kalo... shl468 07/07/14 09:49:17 AM
#3343   Check out my rap videos on YouTube and blackjackmagraw 07/07/14 06:36:32 AM
PostSubject